{"database": "lobbying", "table": "lobbying_activities", "rows": [[2345358, "799960c7-4e54-4c1d-ab4e-b991af458fa0", "Q3", "THE D MAJOR GROUP", 401103162, "ALLERGAN INC (FORMERLY ACTAVIS INC )", 2019, "third_quarter", "CPT", "Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2019-10-16T22:46:57.823000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2345358"], "units": {}, "query_ms": 37.37194591667503, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}